MedTrace Logo

Early Detection of Glioblastoma Multiforme (GBM) Treatment Responses Using Multiple Magnetic Resonance Modalities

NCT00589095 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2014-07-02

No results posted yet for this study

Summary

The purpose of this study is to determine whether dynamic contrast enhanced MRI (DCE MRI) and high diffusion weighting MRI may be used to distinguish between favorable and unfavorable responses to therapy of glioblastoma multiforme. Imaging data will be correlated with histopathologic findings and clinical responses to radiation therapy with or without chemotherapy.

Conditions

Interventions

OTHER

dynamic contrast enhanced magnetic resonance imaging

dynamic contrast enhanced MRI using contrast agent gadodiamide

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Jonathan Knisely, M.D. · Yale University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-11-30
Primary Completion
2011-08-31
Completion
2011-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00589095 on ClinicalTrials.gov